Merantix AI Campus’ Post

Join our next roundtable to hear experts discuss the intersection of genotype imputation and generating polygenic risk scores. They’ll cover strategies for analyzing large-scale datasets and the impact of these methods on research and future patient care. https://hubs.ly/Q02SsLRV0

We are excited to announce our latest report on The State of Steatotic (Fatty) Liver Care in America patient survey has been finalized! One interesting finding, though there are many: the bulk of survey respondents living with MASLD or MASH stated they were diagnosed with MASLD only or Stage 4 MASH. How can we as a community and field move the needle towards earlier diagnosis? We invite you to learn more about the patient experience. Check out the full report here https://bit.ly/4g9iwRD

We have recently updated our patient information & visuals explaining the side-effects of immunotherapies & the likelihood of getting some of the more common side effects. Additional information on fatigue has also been created. 🔎 Updated visuals & info:https://buff.ly/4av4arA 🔎 Fatigue Info:https://buff.ly/4c666s1 Huge thanks to Dr Jo Bird for her initial support with this important project and the invaluable feedback provided by patients and other clinicians. #melanoma #melanomaskincancer #melanomaawareness #immunotherapy #immunotherapies

📢 Save the Date! 📅 Mark your calendars for an upcoming event you won't want to miss! We're thrilled to announce our upcoming webinar "Identifying Patients for MASH Cirrhosis Trials." Join us on August 6th as we delve into innovative strategies for patient identification and the use of NIT’s in cirrhosis trials. Led by Rashmee Patil and Naim Alkhouri, MD, FAASLD, this webinar promises valuable insights and actionable tips for accelerating research in liver health. Stay tuned for more details! #CirrhosisTrials #MedicalResearch #LiverHealth #SaveTheDate

At the heart of Alzheimer’s disease research is the patient experience. C-Path emphasizes patient-centered research to ensure that treatments and trials align with what matters most to those living with the disease. By incorporating patient feedback into tools to support trial designs, C-Path aims to accelerate development of therapies that not only target the disease but improve quality of life. Patient voices are important as they shape the trajectory of Alzheimer’s disease research and help prioritize what needs the most attention. It’s vital to ensure that patients’ voices and their wellbeing aren’t forgotten in scientific progress. Learn more about how C-Path is driving these efforts by visiting c-path.org/cpad. #CPath #AlzheimersDiseaseAwarenessMonth #CPAD #Biomarkers #PatientVoice

How Phylaxis.ai is Transforming Healthcare | Insights with Phithos Technologies & Breast Health Foundation. https://lnkd.in/dVe4i_Rd 🎙️ ETV Live: Real People Tech Stories. An inspiring episode featuring Kabelo Sejaphala, Programme Director at Phithos Technologies, and Louise Turner, COO of the Breast Health Foundation. Together, they share how Phylaxis.ai is empowering Individuals, Communities, and Institutions to improve early-detection. Hear from them on the implementation of data-driven approach for progressively improving the health outcomes and reduce disparities, in-pursuit of bringing down disease burden and associated costs.  #TechForGood #HealthcareInnovation #PhylaxisAI #Phylaxis #PreventativeHealthcare  #OwnYourHealth #ReduceDiseaseBurden

We are thrilled to announce the publication of the current list of participants in our ElevateHealth initiative! This initiative explores how modeling can serve as a common language across healthcare's micro (patient-focused), meso (healthcare system), and macro (ecosystem-wide) levels, fostering collaboration and innovation. As a next step, this vibrant community will launch its first task force dedicated to cardiovascular disease, bringing together diverse expertise to drive impactful outcomes in this critical area of health. The published document includes the emails of our board members, making it easier for you to get in touch for more information or to learn how you can contribute to this open science community. Together, let’s shape the future of healthcare. #HealthcareInnovation #OpenScience #ElevateHealth

📢 Save the Date! 📅 Mark your calendars for an upcoming event you won't want to miss! We're thrilled to announce our upcoming webinar "Identifying Patients for MASH Cirrhosis Trials." Join us on April 25th as we delve into innovative strategies for patient identification and the use of NIT’s in cirrhosis trials. Led by Rashmee Patil and Naim Alkhouri, MD, FAASLD, this webinar promises valuable insights and actionable tips for accelerating research in liver health. Stay tuned for more details! #CirrhosisTrials #MedicalResearch #LiverHealth #SaveTheDate

As we kick off the new year, this Wound Care Wednesday is the perfect time to revisit an impactful series: Foundations of Wound Healing: Exploring Cellular, Acellular, and Matrix Products. 🎉 Whether you're a healthcare professional, caregiver, or simply curious about the latest in wound care, these three episodes provide valuable insights to deepen your understanding and practice: 🎙️ About the Series
Hosted by Dr. Jonathan Johnson in collaboration with ExtremityCare, this 3-part podcast dives into cutting-edge strategies and innovations in wound care: 1️⃣ Part I: Unpacking the science and applications of cellular, acellular, and matrix products with guest Dr. Naz Wahab.
 2️⃣ Part II: Exploring Men's Health, the impact of ischemic disorders on wound healing, and practical tips to improve health outcomes.
 3️⃣ Part III: A deep dive into the evolution of CAMPs (Cellular and Acellular Matrix Products) with Dr. William Tettelbach, focusing on their role in saving limbs and reducing healthcare costs. 🎧 Start listening today on Speaking of Wounds and join the conversation about advancing wound care in 2025! Link: https://lnkd.in/ewsf5Ntr #WoundCareWednesday #SpeakingOfWounds #WoundHealing #HealthcareInnovation #DrWounds

Dr. Samyukta Mullangi shares groundbreaking insights from Thyme Care's navigation program, showcasing a remarkable $594 reduction in total cost of care per engaged member per month. The study's findings underscore Thyme Care's unique and proactive approach to virtual navigation in oncology care — proactively managing treatment symptoms, addressing social determinants of health, and enhancing care coordination, all while delivering meaningful cost savings to the ecosystem. Uncover the strategies driving these cost reductions and the scalability of our model across various contracts. Read more in this recent AJMC - The American Journal of Managed Care article: https://lnkd.in/e84igcVh